Quotulatiousness

November 5, 2015

The high-church organic movement is feeling under threat

Filed under: Business, Environment, Health, Media, Politics, USA — Tags: , , , , — Nicholas @ 02:00

Henry I. Miller & Julie Kelly on the less-than-certain future of the organic farming community:

The organic-products industry, which has been on a tear for the past decade, is running scared. Challenged by progress in modern genetic engineering and state-of-the-art pesticides — which are denied to organic farmers — the organic movement is ratcheting up its rhetoric and bolstering its anti-innovation agenda while trying to expand a consumer base that shows signs of hitting the wall.

Genetic-engineering-labeling referendums funded by the organic industry failed last year in Colorado and Oregon, following similar defeats in California and Washington. Even worse for the industry, a recent Supreme Court decision appears to proscribe on First Amendment grounds the kind of labeling they want. A June 2015 Supreme Court decision has cleared a judicial path to challenge the constitutionality of special labeling — “compelled commercial speech” — to identify foods that contain genetically engineered (sometimes called “genetically modified”) ingredients. The essence of the decision is the expansion of the range of regulations subject to “strict scrutiny,” the most rigorous standard of review for constitutionality, to include special labeling laws.

[…]

Organic agriculture has become a kind of Dr. Frankenstein’s monster, a far cry from what was intended: “Let me be clear about one thing, the organic label is a marketing tool,” said then secretary of agriculture Dan Glickman when organic certification was being considered. “It is not a statement about food safety. Nor is ‘organic’ a value judgment about nutrition or quality.” That quote from Secretary Glickman should have to be displayed prominently in every establishment that sells organic products.

The backstory here is that in spite of its “good vibes,” organic farming is an affront to the environment — hugely wasteful of arable land and water because of its low yields. Plant pathologist Dr. Steve Savage recently analyzed the data from USDA’s 2014 Organic Survey, which reports various measures of productivity from most of the certified-organic farms in the nation, and compared them to those at conventional farms, crop by crop, state by state. His findings are extraordinary. Of the 68 crops surveyed, there was a “yield gap” — poorer performance of organic farms — in 59. And many of those gaps, or shortfalls, were impressive: strawberries, 61 percent less than conventional; fresh tomatoes, 61 percent less; tangerines, 58 percent less; carrots, 49 percent less; cotton, 45 percent less; rice, 39 percent less; peanuts, 37 percent less.

October 31, 2015

Is it a ghost or some boring old rational explanation?

Filed under: Science — Tags: , , , , — Nicholas @ 04:00

Shaunacy Ferro is here to harsh your paranormal mellow with six possible explanations for ghostly activities:

1. ELECTROMAGNETIC FIELDS

For decades, a Canadian neuroscientist named Michael Persinger has been studying the effects of electromagnetic fields on people’s perceptions of ghosts, hypothesizing that pulsed magnetic fields, imperceptible on a conscious level, can make people feel as if there is a “presence” in the room with them by causing unusual activity patterns in the brain’s temporal lobes. […]

2. INFRASOUND

Infrasound is sound at levels so low humans can’t hear it (though other animals, like elephants, can). Low frequency vibrations can cause distinct physiological discomfort. Scientists studying the effects of wind turbines and traffic noise near residences have found that low-frequency noise can cause disorientation, feelings of panic, changes in heart rate and blood pressure, and other effects that could easily be associated with being visited by a ghost [PDF]. […]

3. MOLD

Shane Rogers, an engineering professor at Clarkson University, has spent the past few months touring reportedly haunted locations looking for not-so-paranormal activity: mold growth. Preliminary research indicates that some molds can cause symptoms that sound pretty ghostly—like irrational fear and dementia. […]

4. CARBON MONOXIDE POISONING

In 1921, a doctor named W.H. Wilmer published an odd story about a haunted house in the medical journal the American Journal of Ophthalmology. The family who lived in this haunted residence, called the H family in the medical literature, began experiencing weird phenomena when they moved into an old house—hearing furniture moving around and strange voices in the night, feeling the presence of invisible specters. They report being held down in bed by ghosts, feeling weak, and more. As it turned out, a faulty furnace was filling their house with carbon monoxide, causing aural and visual hallucinations. The furnace was fixed, and the H family went back to their lives, sans ghosts.

5. SOMEONE ELSE SAID IT WAS REAL.

In a 2014 study, Goldsmiths, University of London psychologists had participants watch a video of a “psychic” supposedly bending a metal key with his mind. In one condition, study subjects watched the video with a “participant” who was actually working with the researchers and professed to see the key bending. Those subjects were more likely to report that they saw the key bend than subjects who were paired with someone who asserted that the key didn’t bend or said nothing. […]

6. WE WANT TO BELIEVE.

“There is a motivational side to belief in ghosts,” French explains. “We all want to believe in life after death. The idea of our mortality is one we are not generally comfortable with.” Confirmation bias holds powerful sway over our perceptions. “We find it much easier to believe evidence for something we want to believe anyway,” he says.

The chemistry of cider

Filed under: Science — Tags: , — Nicholas @ 02:00

At Compound Interest, a look at the making of cider:

On a hot summer’s day, the cool, refreshing taste of cider is hard to beat. But what are the chemicals behind this flavour?

Before we look at the chemistry, let’s briefly discuss how cider is made. Obviously, it starts with the apples being picked from the tree. The type of apples is, of course, a major factor in the taste of the finished cider. Bittersweet cider apples are low on acidity, but high on tannins, whilst sharp apples are the opposite. Sweet apples, meanwhile, are low in both departments, whilst bittersharp apples are high in both.

Once the apples have been picked, they’re left to mature for a time before then being scratted, or ground down, into a pulp. The pulp produced by this process is known as pomace. This pomace is then pressed to squeeze out all of the juice, which is collected into either vats or casks. At this point, it is then slowly fermented, and yeasts convert the natural sugars in the apples into alcohol. These yeasts can be the natural yeasts present in the apples, or yeasts that are added specifically for fermentation.

After fermentation is complete, the cider will often be left to mature for several months. At this point, extra sugar is sometimes added to the cider to allow fermentation to continue, and produce a small amount of carbon dioxide to carbonate the cider. However, commercially carbonation is often primarily accomplished via direct injection of carbon dioxide. In the manufacture of some ciders, they may be blended with other, older ciders, to ensure consistency of taste or to alter the flavour.

Click to see full-sized infographic at Compound Interest.

Click to see full-sized infographic at Compound Interest.

October 28, 2015

The WHO’s lack of clarity leads to sensationalist newspaper headlines (again)

Filed under: Health, Media, Science — Tags: , , , , , — Nicholas @ 05:00

The World Health Organization appears to exist primarily to give newspaper editors the excuse to run senational headlines about the risk of cancer. This is not a repeat story from earlier years. Oh, wait. Yes it is. Here’s The Atlantic‘s Ed Yong to de-sensationalize the recent scary headlines:

The International Agency of Research into Cancer (IARC), an arm of the World Health Organization, is notable for two things. First, they’re meant to carefully assess whether things cause cancer, from pesticides to sunlight, and to provide the definitive word on those possible risks.

Second, they are terrible at communicating their findings.

[…]

Group 1 is billed as “carcinogenic to humans,” which means that we can be fairly sure that the things here have the potential to cause cancer. But the stark language, with no mention of risks or odds or any remotely conditional, invites people to assume that if they specifically partake of, say, smoking or processed meat, they will definitely get cancer.

Similarly, when Group 2A is described as “probably carcinogenic to humans,” it roughly translates to “there’s some evidence that these things could cause cancer, but we can’t be sure.” Again, the word “probably” conjures up the specter of individual risk, but the classification isn’t about individuals at all.

Group 2B, “possibly carcinogenic to humans,” may be the most confusing one of all. What does “possibly” even mean? Proving a negative is incredibly difficult, which is why Group 4 — “probably not carcinogenic to humans” — contains just one substance of the hundreds that IARC has assessed.

So, in practice, 2B becomes a giant dumping ground for all the risk factors that IARC has considered, and could neither confirm nor fully discount as carcinogens. Which is to say: most things. It’s a bloated category, essentially one big epidemiological shruggie. But try telling someone unfamiliar with this that, say, power lines are “possibly carcinogenic” and see what they take away from that.

Worse still, the practice of lumping risk factors into categories without accompanying description — or, preferably, visualization — of their respective risks practically invites people to view them as like-for-like. And that inevitably led to misleading headlines like this one in the Guardian: “Processed meats rank alongside smoking as cancer causes – WHO.”

Reducing the costs of regulation

Filed under: Bureaucracy, Government, Health, USA — Tags: , , — Nicholas @ 04:00

Henry I. Miller discusses a worthwhile regulatory change that would increase the availability of medicines in the US marketplace without reducing public safety:

The FDA would be a good place to start. Bringing a new drug to market now requires 10-15 years, and costs have skyrocketed to an average of more than $2.5 billion (including both out-of-pocket and opportunity costs) – largely because FDA requirements have increased the length and number of clinical trials per marketing application, and their complexity.

The detrimental effects of FDA delays in approving certain new drugs already available in other industrialized countries are well-documented and deserve as much attention as drugs’ high costs. An example is the three-year delay in the approval of misoprostol, a drug for the treatment of gastric bleeding, which is estimated to have cost between 8,000 and 15,000 lives per year.

[…]

A practical workaround to overcome regulators’ risk-aversion and capriciousness would be “reciprocity” of approvals with certain foreign “A-list” governments, so that an approval in one country would be reciprocated automatically by the others. That would make more drugs available sooner in all of the participating countries, increasing competition and putting downward pressure on prices.

Such an innovation would also help to alleviate another critical problem: The United States is experiencing shortages of certain critical pharmaceuticals, many of which have been essential in medical practice for decades. The majority are generic injectable medications commonly used in hospitals, including analgesics, cancer drugs, anesthetics, antipsychotics for psychiatric emergencies, and electrolytes needed for patients on IV supplementation. Hospitals are scrambling to assure adequate supplies of drugs that are in short supply, or to find substitutes for them. Reciprocal approvals would make numerous alternatives available.

As referenced yesterday, the FDA regulations also create temporary monopoly situations where only one company has the permit from the regulator to produce this or that medicine, so there’s nothing standing in the way of massive price increases if there are no close substitutes to provide price competition.

October 27, 2015

Update on that $750 pill and the regulatory system that made it inevitable

Filed under: Bureaucracy, Business, Health — Tags: , , — Nicholas @ 05:00

Tim Worstall follows up on all-world scumbag Martin Shkreli and his enabled-by-the-regulator insane price increases for a decades-old drug:

We have an interesting and important economic lesson for public policy here: markets, they work. More accurately, we don’t have to worry about someone attempting to exploit their possession of a contestable monopoly. We only have to worry, possibly take action, if someone has an uncontestable monopoly. And given that there’s very few of them that we don’t create ourselves for other reasons, this means that monopoly is just one of those things we can keep a wary eye upon but not worry over excessively.

Our example comes from Martin Shkreli. The basic background is that this entrepreneur thinks he’s found a pretty cool business model. There’s a number of pharmaceuticals out there that are well out of patent but still have small and useful markets. FDA regulations (no, we’ll not go into the details of how or why this happens) mean that it’s not as easy as one might think to produce generic versions of these out of patent drugs. So, as a business plan, buy up the rights to the permit-ed (as in, with a permit, not just those allowed, as in permitted) generics and as a result of the difficulty someone else will have in getting into the same market, some pricing power is available. You can then raise the price and start to bank your considerable profits.

This caused outrage when Shkreli announced that this was exactly what he was doing:

    Turing Pharmaceuticals, the company that last month raised the price of the decades-old drug Daraprim from $13.50 a pill to $750…

A 5,000% price rise certainly indicates that Turing thinks it has pricing power and thus that it has considerable monopoly power.

[…]

Markets, they work. As Mr. Shkreli is just finding out:

    Turing Pharmaceuticals, the company that last month raised the price of the decades-old drug Daraprim from $13.50 a pill to $750, now has a competitor.

    Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company based in San Diego, announced today that it has made an alternative to Daraprim that costs about a buck a pill — or $99 for a 100-pill supply.

This is not the same drug: it’s a slight variation, a close substitute. But it’s close enough that Turing isn’t going to be making much money from what it thought was monopoly pricing power. Because it was a contestable monopoly, not an absolute one.

October 26, 2015

Consumers of porn have more feminist attitudes

Filed under: Cancon, Health, Media — Tags: , , , — Nicholas @ 02:00

We’ve all heard the claim that pornography desensitizes those who view it and dehumanizes women … except that doesn’t seem to be the case, if a recent study is accurate:

The study, published in The Journal of Sex Research, was conducted by researchers at the University of Western Ontario. “According to radical feminist theory, pornography serves to further the subordination of women by training its users, males and females alike, to view women as little more than sex objects over whom men should have complete control,” they wrote in the study abstract.

Yet after comparing people who watch porn with those who don’t, researchers found those who had watched an adult film at least once in the past year held more egalitarian ideas about women in positions of power and women working outside the home, along with more positive views toward abortion. The two groups did not differ significantly in attitudes about “traditional” families or self-identification as feminist.

“Taken together, the results of this study fail to support the view that pornography is an efficient deliverer of ‘women-hating ideology,'” study authors concluded. “While unexpected from the perspective of radical feminist theory, these results are consistent with a small number of empirical studies that have also reported positive associations between pornography use and egalitarian attitudes.”

Researchers relied on data collected between 1975 and 2010 for the General Social Survey, which asks Americans about a wide range of social issues and personal views (including gender equality and personal pornography consumption). For both men and women, viewing porn was associated with more positive attitudes toward women holding positions of power, less negative views of abortion, and less negative attitudes toward women in the workplace.

October 22, 2015

QotD: The historical triumph of public health

Filed under: Bureaucracy, Government, Health, History, Quotations — Tags: , — Nicholas @ 01:00

… the great public health achievements between roughly 1850 and 1960. Doctors and public health experts were given extraordinarily broad powers by the government, and they used them to eliminate the scourges that had made cities into pestholes from time immemorial. They built gleaming sewers and water treatment plants to wipe out virulent water-borne pathogens that used to regularly claim thousands of lives. Contact-tracing and quarantine of airborne and sexually transmitted diseases turned former plagues like smallpox and syphilis into tragic but sporadic outbreaks. Changes in building codes helped beat back mass killers like tuberculosis. Poison control cut down on both accidental and deliberate deaths. The Pure Food and Drug Act, and similar ordinances in other countries, reduced foodborne illness, and also, the casual acquisition of opiate or cocaine addictions through patent medicines. Malarial swamps were drained. Environmental toxins were identified and banned. Then they went and invented antibiotics and vaccines and vaccination laws, and suddenly surgery was as safe as a long-haul flight, TB was curable, and childhood illnesses that used to kill hundreds of people every year were a quaint footnote in your 10th-grade history textbook.

Having seen public experts work these miracles through the heavy hand of the state, people understandably concluded we could use miracles in other areas. They had a metaphor, so to speak. The metaphor wasn’t very good, as is often the case, but it took a while to find out that you couldn’t solve a problem in your steel supply chain with the same system that was so good at tracing cholera outbreaks to tainted pumps.

[…]

This is an overreaction to a terrible failure, for two reasons. First, big bureaucracies fail all the time, especially in the face of novel threats. A large institution is like a battleship: hard to sink, but also hard to turn. Public health experts of earlier eras made grave mistakes, like dumping London’s untreated sewage into the Thames; public health experts of the future will too. The more important question is whether they correct themselves, as it seems to me the CDC is now doing.

The second is that this is not your grandfather’s public health system. Public health experts were, in a way, too successful; they beat back our infectious disease load to the point where most of us have never had anything more serious than Human papillomavirus or a bad case of the flu. This left them without that much to do. So they reinvented themselves as the overseers of everything that might make us unhealthy, from French Fries to work stress.

As with the steel mills, these problems are not necessarily amenable to the organizational tools used to tackle tuberculosis. The more the public and private health system are focused on these problems, the less optimized they will be for fighting the war against infectious disease. It is less surprising to find that they didn’t know how to respond to a novel infectious disease than it would have been to discover that they botched a new campaign against texting and driving.

Megan McArdle, “Will Ebola Be Good for the CDC?”, Bloomberg View, 2014-10-20.

October 16, 2015

QotD: This explains so much

Filed under: Health, Humour, Quotations, Science — Tags: , — Nicholas @ 01:00

The entire brain weighs three pounds (1.4 kg) and so is only a small percentage of an adult’s total body weight, typically 2%. But it consumes 20% of all the energy the body uses. Why? The perhaps oversimplified answer is that time is energy.

Neural communication is very rapid — it has to be — reaching speeds of over 300 miles per hour and with neurons communicating with one another hundreds of times per second. The voltage output of a single resting neuron is 70 millivolts, about the same as the line output of an iPod. If you could hook up a neuron to a pair of earbuds, you could actually hear its rhythmic output as a series of clicks.

[…]

Neurochemicals that control communication between neurons are manufactured in the brain itself. These include some relatively well-known ones such as serotonin, dopamine, oxytocin, and epinephrine, as well as acetylcholine, GABA, glutamate, and endocannabinoids. Chemicals are released in very specific locations and they act on specific synapses to change the flow of information in the brain. Manufacturing these chemicals, and dispersing them to regulate and modulate brain activity, requires energy — neurons are living cells with a metabolism, and they get that energy from glucose. No other tissue in the body relies solely on glucose for energy except the testes. (This is why men occasionally experience a battle for resources between their brains and their glands.)

Daniel J. Levitin, The Organized Mind, 2014.

October 15, 2015

Carbohydrates and fatty foods

Filed under: Food, Health, Science, USA — Tags: — Nicholas @ 04:00

Amy Alkon glories in her current dietary choices:

I spend my whole day eating fat — bacon fat, kale cooked in bacon fat, an omelet with cheese and pate, coffee made with half ‘n’ half; and steak, sausage, cheese, and green beans swimming in butter. Oh, also, a tablespoon of coconut oil warmed in half ‘n’ half a few times a day, whenever my brain feels like it’s on fire from intense activity.

I have never felt better.

And I’m never hungry the way I would get when I ate low-fat/high-carb — a hunger that made me feel like I could stop and devour a road sign (and anyone unlucky enough to be standing next to it at the time).

On the subject of hunger’s effect on diet maintenance, Gary Taubes has an op-ed in The New York Times that describes a study, taking place toward the end of World War Ii, that placed men on a starvation diet:

    For 24 weeks, these men were semi-starved, fed not quite 1,600 calories a day of foods chosen to represent the fare of European famine areas: “whole-wheat bread, potatoes, cereals and considerable amounts of turnips and cabbage” with “token amounts” of meat and dairy.

    As diets go, it was what nutritionists today would consider a low-calorie, and very low-fat diet, with only 17 percent of calories coming from fat.

There were horrible physical effects — and psychological ones. Two men had breakdowns. And then, when they were allowed to eat normally, they consumed “prodigious” amounts of food…eating themselves into “post-starvation obesity,” in the researchers’ words.

[…]

    Questions like these about the relationship between calories, macronutrients and hunger have haunted nutrition and obesity research since the late 1940s. But rarely are they asked. We believe so implicitly in the rationale of eat less, move more, that we (at least those of us who are lean) will implicitly fault the obese for their failures to sustain a calorie-restricted regimen, without ever apparently asking ourselves whether we could sustain it either. I have a colleague who spent his research career studying hunger. Asking people to eat less, he says, is like asking them to breathe less. It sounds reasonable, so long as you don’t expect them to keep it up for long.

October 13, 2015

Britain’s National Health Service runs up a “deficit of almost £1 billion in just three months”

Filed under: Britain, Government, Health — Tags: , — Nicholas @ 04:00

In the Telegraph a report on the dire financial straits of Britain’s NHS:

NHS trusts in England have racked up a deficit approaching £1 billion in the first three months of the financial year – the worst financial position “in a generation,” regulators have said.

The figure is more than the £820 million overspend for the entire previous year.

Experts warned of a looming winter crisis.

They said the “staggering” figures would result in widespread cutbacks to services, with lengthening waiting times and increased rationing of care.

The statistics for April to June show an overall deficit of £930m across England’s 241 NHS hospital trusts, with three in four trusts in the red.

The statistics show NHS Foundation Trusts had a deficit of £445 million. Other NHS trusts ended the first quarter of the year £485 million in deficit.

The foundation trust sector is under “massive pressure” and can no longer afford to go on as it is, the financial regulator Monitor said.

Regulators said an “over-reliance” on agency nurses and doctors to plug shortages of staff was fuelling the growing debt, which is forecast to reach a record high.

October 9, 2015

Recalculating the impact of carbon dioxide in the climate models

Filed under: Environment, Science — Tags: , — Nicholas @ 04:00

A few people sent me a link to this article, which may be of interest to those following the ongoing climate debates:

It turns out the UN’s Intergovernmental Panel on Climate Change has over-estimated future global warming by as much as 10 times, [Dr David Evans] says.

“Yes, CO2 has an effect, but it’s about a fifth or tenth of what the IPCC says it is. CO2 is not driving the climate; it caused less than 20 per cent of the global warming in the last few decades”.

Dr Evans says his discovery “ought to change the world”.

“But the political obstacles are massive,” he said.

His discovery explains why none of the climate models used by the IPCC reflect the evidence of recorded temperatures. The models have failed to predict the pause in global warming which has been going on for 18 years and counting.

“The model architecture was wrong,” he says. “Carbon dioxide causes only minor warming. The climate is largely driven by factors outside our control.”

There is another problem with the original climate model, which has been around since 1896.

While climate scientists have been predicting since the 1990s that changes in temperature would follow changes in carbon dioxide, the records over the past half million years show that not to be the case.

So, the new improved climate model shows CO2 is not the culprit in recent global warming. But what is?

Dr Evans has a theory: solar activity. What he calls “albedo modulation”, the waxing and waning of reflected radiation from the Sun, is the likely cause of global warming.

He predicts global temperatures, which have plateaued, will begin to cool significantly, beginning between 2017 and 2021. The cooling will be about 0.3C in the 2020s. Some scientists have even forecast a mini ice age in the 2030s.

October 8, 2015

“[P]harmaceutical companies … make out like bandits from the existence of the patent system”

Filed under: Bureaucracy, Business, Health, Law, USA — Tags: , , , — Nicholas @ 05:00

The current US patent system is set up to create and maintain — for a limited time — monopolies that can be exploited by pharmaceutical companies:

The Wall Street Journal has a puzzling piece complaining about how the pharmaceutical companies seem to make out like bandits from the existence of the patent system. What puzzles is that the entire point and purpose of the patent system, in an economic sense, is so that inventors of things can make out like bandits. The background problem is that of public goods, something I’ll explain in a moment. That problem leads us to thinking that a pure free market in things which are public goods isn’t going to work as well as something a little different. So, we design something a little different. And the point and purpose of our design is so that people who innovate can make vast mountains of cash out of having done so.

It’s then more than a bit odd to point out that our system enables people who innovate to make vast mountains of cash.

[…]

Which brings us to the subtlety of those pricing decisions. With drugs, pharmaceuticals, close enough the cost of manufacturing a dose is zero. All of the costs go in the original research, the clinical testing (the lion’s share) and getting it through the FDA. Profit is therefore determined, since marginal production costs are zero (they’re not, accurately, but close enough for this comparison), by gross revenue. And we want to maximise the incentive for people to innovate, that’s the very reason we’ve got this patent system in the first place, and thus we would rather like the pharma companies to be maximising revenue.

And thus, from this economic point of view, we should be quite happy with people raising their prices. Demand does fall as they do so, yes, but as long as gross revenue increases, the price rises more than compensating for the fall in unit demand, then we should be happy with the way the system is working. Gross revenue is being maximised, profits are being maximised, incentives to innovate are being maximised. That’s what we want our system to do after all.

Far from being worried about this price gouging we should be welcoming it. Because, obviously, someone making bajillions out of having innovated a drug to cure a disease increases the incentives for many other people to go and invest bajillions of their own to cure other diseases. Far from complaining about it we should be celebrating the system working.

Science as horse racing

Filed under: Science — Tags: , , , , — Nicholas @ 04:00

In Wired, Sarah Zhang handicaps the horses in this year’s highly competitive Nobel Sweepstakes:

Nobel prize speculation, gossip, and betting pools kick off every fall around the time Thomson Reuters releases its predictions for science’s most prestigious prize. This year, one prediction was unusual: a genome-editing tool so hyped that it even got on the cover of WIRED.

(No, seriously, how often does molecular biology get to occupy the same space as Star Wars or Rashida Jones?)

The tool, Crispr/Cas9, is essentially a pair of molecular scissors for editing DNA, so precise and easy to use that it has taken biology by storm. Hundreds if not thousands of labs now use Crispr/Cas9 to do everything from making super-muscled pigs to snipping HIV genes out of infected cells to creating transgenic monkeys for neuroscience research. But the Nobel prediction stands out for two reasons: First, the highly-cited paper describing Crispr/Cas9 came out a mere three years ago, a blip in the timescale of science. Second, the technique is currently at the heart of a bitter patent fight.

Thomson Reuters bases its predictions on how often key papers get cited by other scientists. Here, the paper in question has as its authors Jennifer Doudna, a molecular biologist at UC Berkeley, and Emmanuelle Charpentier, a microbiologist now at the Max Planck Institute for Infection Biology. Missing is Feng Zhang (no relation to this writer), a molecular biologist at the Broad Institute and MIT, who actually owns the patents for CRISPR/Cas9 and says that he came up with the idea independently. So let’s say Thomson Reuters gets it right. Could the patent for a discovery go to one scientist, and the Nobel prize for the discovery to someone else?

The two groups — or their patent lawyers, really — are in fact fighting over credit for CRISPR/Cas9. At stake are millions of dollars already poured into rival companies that have licensed patents from the two different groups.

But putting aside all the lawyers and all the money for a moment, obsessing over finding the one true origin of Crispr/Cas9 gets science all wrong. Casting the narrative as Doudna versus Zhang or Berkeley versus MIT is a misapprehension of history, creativity, and innovation. Discovery comes not from a singular stroke of genius, but an incremental body of research. “I’m not a great believer in the flash-of-genius theory. If you are a historian —” says Mario Biagioli, who is in fact a historian of science at UC Davis — “you quickly will realize exactly how many times there are independent discoveries of the same thing.” The dispute over credit for CRISPR/Cas9 is not the result of exceptional coincidence and disagreement. In fact, it illuminates how science always works.

October 7, 2015

A Deeper Look at Tradeable Allowances

Filed under: Economics, Environment — Tags: , , , , , — Nicholas @ 03:00

Published on 18 Mar 2015

Since the passage of the Clean Air Act, SO2 emissions have decreased by 35%. Part of this is due to tradable allowances, which created a market solution to the external costs of SO2 emissions. In this video, we look at the lessons of tradable allowances for SO2 and see if a similar market-based solution could work to decrease other pollutants, such as CO2.

« Newer Posts — Older Posts »

Powered by WordPress